External Source

Updated Data With Larotrectinib In Trk Fusion-positive Solid Tumors

2019 1:20
Synopsis
David S. Hong, MD, deputy director of the Department of investigational Cancer Therapeutics, Division of Cancer Medicine, The ...

You Might Also Like

Dr Subbiah on Outcomes With Larotrectinib in TRK Fusion–Positive Solid Tumors 1:06
Dr Subbiah On Outcomes With Larotrectinib In Trk Fusion–po...
2024
Larotrectinib, a TRK inhibitor for patients with solid tumors 1:15
Larotrectinib, A Trk Inhibitor For Patients With Solid Tumor...
2021
Larotrectinib in adult and pediatric patients with TRK fusion-positive primary CNS tumors 3:18
Larotrectinib In Adult And Pediatric Patients With Trk Fusio...
2021
Larotrectinib for Solid Tumors With NTRK Gene Fusions 7:14
Larotrectinib For Solid Tumors With Ntrk Gene Fusions
2019
Larotrectinib Is Well-Tolerated in Metastatic Solid Tumors 0:39
Larotrectinib Is Well-tolerated In Metastatic Solid Tumors
2020
Updated Data for Larotrectinib 4:25
Updated Data For Larotrectinib
2019
Larotrectinib for NTRK Fusions: Patient Selection 5:08
Larotrectinib For Ntrk Fusions: Patient Selection
2019
The impact of TRK inhibitor LOXO-101 (larotrectinib) on patients with TRK fusion cancers 0:52
The Impact Of Trk Inhibitor Loxo-101 (larotrectinib) On Pati...
2017
Analyzing Response Rates With Larotrectinib 4:16
Analyzing Response Rates With Larotrectinib
2019
Approaching Treatment for TRK Fusion–Positive Cancers 3:20
Approaching Treatment For Trk Fusion–positive Cancers
2020
Efficacy of TRKi–Larotrectinib Among Tumor Types 6:47
Efficacy Of Trki–larotrectinib Among Tumor Types
2019
Download Options
Choose a download method below. All links open in new tabs.
Service Features Action
SaveFrom
MP4 & MP3 • HD Quality • Browser Extension Available
Download
Security Notice: These are third-party services. We recommend using antivirus software and being cautious of pop-up ads.